Holding(s) in Company

For immediate release 

5 November 2009

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Neuropharm Group plc

2. Reason for the notification  

An acquisition or disposal of voting rights

Yes

Other (please specify):

Disclosure of holdings follows the sale of Insight Investment Management Limited on 2 November 2009. This notification supersedes any notifications previously issued by Lloyds Banking Group plc.

3. Full name of person(s) subject to the notification obligation:

Lloyds Banking Group plc

4. Full name of shareholder(s) (if different from 3.):

See Section 9.

5. Date of the transaction and date on which the threshold is crossed or reached:

02 November 2009

6. Date on which issuer notified:

04 November 2009

7. Threshold(s) that is/are crossed or reached:

N/A - direct/indirect holdings remain above 9%

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the Triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares Direct

Number of voting rights

% of voting rights

Direct

Indirect

Direct

Indirect

Ord 10p Shares

3,036,615

3,036,615

1,328,394

1,328,394

1,708,222

4.212%

5.417%

GB00B1NPJJ01

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument 

Expiration date

Exercise/ Conversion Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/ converted 

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments 

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Number of voting rights instrument refers to

% of voting rights 

Total (A+B+C)

Number of voting rights

% of voting rights

3,036,616

9.629%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

3,036,607 shares (9.629%) are under the control of Scottish Widows Investment Partnership Ltd, a wholly owned subsidiary of Scottish Widows Group Ltd, a wholly owned subsidiary of Lloyds TSB Bank plc, a wholly owned subsidiary of Lloyds Banking Group plc (Direct/Indirect Interests).

Within these holdings 22,658 shares (0.072%) are managed on behalf of Clerical Medical Managed Funds Limited a wholly owned subsidiary of Clerical Medical Investment Group Limited, and a further 1,305,727 shares (4.140%) are managed on behalf of Clerical Medical Investment Group Limited, a wholly owned subsidiary of HBOS Financial Services Limited, a wholly owned subsidiary of HBOS Insurance & Investment Group Limited a wholly owned subsidiary of HBOS plc, a wholly owned subsidiary of Lloyds Banking Group plc, These holdings are therefore disclosed as an overall Direct Interest.

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

Notification using the Total Voting Rights figure of 31,536,697

14. Contact name:

Matthew Wilson

15. Contact telephone number:

0113 235 7729